Literature DB >> 8741794

Preventive strategies and research for ultraviolet-associated cancer.

H K Koh1.   

Abstract

Ultraviolet (UV)-associated cancer is the most common cancer in the United States. Approximately 90% of nonmelanoma skin cancer and 65% of melanoma are attributable to UV exposure and theoretically could be eliminated by primary prevention measures. Safe sun strategy includes use of sunscreens, use of protective clothing, minimization of exposure from 10 A.M. to 3 P.M., and avoidance of tanning parlors. Although more definitive data in human populations on the effectiveness of sunscreens to prevent melanoma and skin cancer are needed, sunscreens are thought to reduce risk. Safe sun prevention must start in childhood and adolescence when people receive most of their UV exposure. Secondary prevention through professional and public education and early detection may further reduce melanoma mortality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8741794      PMCID: PMC1518958          DOI: 10.1289/ehp.95103s8255

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  20 in total

Review 1.  Nonmelanoma cancers of the skin.

Authors:  D S Preston; R S Stern
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

Review 2.  Cutaneous melanoma.

Authors:  H K Koh
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

3.  Evaluating the efficacy of skin self-exam and other surveillance measures in persons at various levels of risk for cutaneous malignant melanoma: an ongoing case-control study.

Authors:  M Berwick; G Roush; W D Thompson
Journal:  Prog Clin Biol Res       Date:  1989

Review 4.  Early detection of melanoma: an ounce of prevention may be a ton of work.

Authors:  H K Koh; A C Geller; D R Miller; R A Lew
Journal:  J Am Acad Dermatol       Date:  1993-04       Impact factor: 11.527

Review 5.  Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin.

Authors:  R J Friedman; D S Rigel; M K Silverman; A W Kopf; K A Vossaert
Journal:  CA Cancer J Clin       Date:  1991 Jul-Aug       Impact factor: 508.702

6.  Who discovers melanoma? Patterns from a population-based survey.

Authors:  H K Koh; D R Miller; A C Geller; R W Clapp; M B Mercer; R A Lew
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

7.  Sunscreens prevent ultraviolet photocarcinogenesis.

Authors:  L H Kligman; F J Akin; A M Kligman
Journal:  J Am Acad Dermatol       Date:  1980-07       Impact factor: 11.527

8.  Atmospheric sun protection factor on clear days: its observed dependence on solar zenith angle and its relevance to the shadow rule for sun protection.

Authors:  L Holloway
Journal:  Photochem Photobiol       Date:  1992-08       Impact factor: 3.421

Review 9.  Screening for melanoma/skin cancer: theoretic and practical considerations.

Authors:  H K Koh; R A Lew; M N Prout
Journal:  J Am Acad Dermatol       Date:  1989-02       Impact factor: 11.527

10.  Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease.

Authors:  G D Masri; W H Clark; D Guerry; A Halpern; C J Thompson; D E Elder
Journal:  J Am Acad Dermatol       Date:  1990-06       Impact factor: 11.527

View more
  9 in total

1.  Cyanidin-3-glucoside inhibits UVB-induced oxidative damage and inflammation by regulating MAP kinase and NF-κB signaling pathways in SKH-1 hairless mice skin.

Authors:  Poyil Pratheeshkumar; Young-Ok Son; Xin Wang; Sasidharan Padmaja Divya; Binoy Joseph; John Andrew Hitron; Lei Wang; Donghern Kim; Yuanqin Yin; Ram Vinod Roy; Jian Lu; Zhuo Zhang; Yitao Wang; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-22       Impact factor: 4.219

2.  Blackberry extract inhibits UVB-induced oxidative damage and inflammation through MAP kinases and NF-κB signaling pathways in SKH-1 mice skin.

Authors:  Sasidharan Padmaja Divya; Xin Wang; Poyil Pratheeshkumar; Young-Ok Son; Ram Vinod Roy; Donghern Kim; Jin Dai; John Andrew Hitron; Lei Wang; Padmaja Asha; Xianglin Shi; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-11       Impact factor: 4.219

3.  Estimating avoidable causes of cancer.

Authors:  D L Davis; C Muir
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

4.  Chemopreventive effects of sarcophine-diol on ultraviolet B-induced skin tumor development in SKH-1 hairless mice.

Authors:  Xiaoying Zhang; Ajay Bommareddy; Wei Chen; Michael B Hildreth; Radhey S Kaushik; David Zeman; Sherief Khalifa; Hesham Fahmy; Chandradhar Dwivedi
Journal:  Mar Drugs       Date:  2009-04-30       Impact factor: 5.118

5.  Predictors of sun protection in Canadian adults.

Authors:  Mark P Purdue
Journal:  Can J Public Health       Date:  2002 Nov-Dec

6.  Ultraviolet irradiation-induces epidermal growth factor receptor (EGFR) nuclear translocation in human keratinocytes.

Authors:  Yiru Xu; Yuan Shao; Jin Zhou; John J Voorhees; Gary J Fisher
Journal:  J Cell Biochem       Date:  2009-08-01       Impact factor: 4.429

7.  Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.

Authors:  Chandeshwari Chilampalli; Ruth Guillermo; Xiaoying Zhang; Radhey S Kaushik; Alan Young; David Zeman; Michael B Hildreth; Hesham Fahmy; Chandradhar Dwivedi
Journal:  BMC Cancer       Date:  2011-10-20       Impact factor: 4.430

Review 8.  Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy.

Authors:  F P Gasparro
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

9.  Dose-response on the chemopreventive effects of sarcophine-diol on UVB-induced skin tumor development in SKH-1 hairless mice.

Authors:  Ruth F Guillermo; Xiaoying Zhang; Radhey S Kaushik; David Zeman; Safwat A Ahmed; Sherief Khalifa; Hesham Fahmy; Chandradhar Dwivedi
Journal:  Mar Drugs       Date:  2012-09-24       Impact factor: 6.085

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.